|
|
|
By Advancing RNA Live | As CRISPR technology evolves beyond the original Cas9, gRNAs are transitioning from simple targeting tools to highly engineered, complex molecules. In this Advancing RNA Live, April Sena, Max De Long, and Venkat Krishnamurthy discuss how the rise of diverse nucleases, including prime editors, is impacting gRNA synthesis and purity. | |
|
|
|
|
|
| 6 Trends Redefining Biologics Manufacturing In 2026 | Article | Jubilant HollisterStier | Modern bioprocessing relies on smarter fill tech, automation, and data-driven methods. Explore how these shifts lower process risk, boost operational efficiency, and protect high-value products. |
|
|
| Screening T7 Polymerases To Optimize xRNA Yield And Quality | Article | By Jing Zhu, Ph.D., Recipharm Advanced Bio | Modern T7 enzyme variants are changing RNA synthesis. Evaluate performance, cost, and supply chain trade-offs to select the right polymerase options for scalable xRNA manufacturing needs. |
|
|
|
|
|
| Building Stability Through Integrated Cryopreservation | Article | Cryoport Systems | Early integration of standardized, GMP-aligned cryopreservation improves consistency, documentation, and scalability in advanced therapy programs as they progress toward regulatory submissions. |
|
|
|
|
|
|
.png){kind=logo}
